Edition:
United Kingdom

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

0.21USD
9:00pm BST
Change (% chg)

$-0.02 (-9.17%)
Prev Close
$0.23
Open
$0.22
Day's High
$0.22
Day's Low
$0.21
Volume
79,305
Avg. Vol
108,864
52-wk High
$2.56
52-wk Low
$0.19

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.104
Sep '18 0.00 -0.632
Jun '18 0.00 -0.378
Mar '18 0.00 -0.266
FY 2017 Dec '17 0.00 -0.139
Sep '17 0.00 -0.603
Sep '17 0.00 -0.075
Dec 0.00 -0.600
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 1 0.00 0.00 0.00 --
Year Ending Dec-20 1 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Dec-19 1 -0.56 -0.56 -0.56 --
Year Ending Dec-20 1 -0.47 -0.47 -0.47 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 109.48 62.40
P/E High - Last 5 Yrs. -- 163.07 56.31
P/E Low - Last 5 Yrs. -- 52.30 28.72
Beta 1.49 1.16 0.93
Price to Sales (TTM) -- 46.04 9.62
Price to Book (MRQ) 20.04 13.22 4.53
Price to Tangible Book (MRQ) -- 18.84 7.71
Price to Cash Flow (TTM) -- 73.00 43.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.09 1.54
Dividend Yield - 5 Year Avg -- 0.05 0.70
Dividend 5 Year Growth Rate -- 0.72 2.97
Payout Ratio(TTM) -- 8.42 21.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 23.35 9.20
Sales (TTM) vs TTM 1 Yr. Ago -- 67.54 8.35
Sales - 5 Yr. Growth Rate -- 33.23 11.12
EPS (MRQ) vs Qtr. 1 Yr. Ago 24.92 -90.23 110.61
EPS (TTM) vs TTM 1 Yr. Ago 6.58 -- --
EPS - 5 Yr. Growth Rate -- 21.68 6.92
Capital Spending - 5 Yr. Growth Rate -- 25.56 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.71 2.66
Current Ratio (MRQ) 1.04 3.55 3.63
LT Debt to Equity (MRQ) 0.00 7.07 13.26
Total Debt to Equity (MRQ) 72.91 20.06 16.97
Interest Coverage (TTM) -- 10.02 27.27

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 25.18 50.31
Gross Margin - 5 Yr. Avg. -- 59.97 50.77
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -10.84 15.78
Operating Margin (TTM) -- -109.08 -2.09
Operating Margin - 5 Yr. Avg. -- -26.44 11.11
Pre-Tax Margin (TTM) -- -109.66 -2.92
Pre-Tax Margin - 5 Yr. Avg. -- -29.17 16.76
Net Profit Margin (TTM) -- -116.04 -6.86
Net Profit Margin - 5 Yr. Avg. -- -34.35 11.72
Effective Tax Rate (TTM) -- 19.91 22.86
Effective Tax Rate - 5 Yr. Avg. -- 19.61 23.86

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 8,511,584 773,166,387
Net Income/Employee (TTM) -639,236 1,995,061 89,056,262
Receivable Turnover (TTM) -- 2.36 5.22
Inventory Turnover (TTM) -- 2.31 3.65
Asset Turnover (TTM) 0.00 0.32 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -92.06 6.35 9.54
Return on Assets - 5 Yr. Avg. -- 6.24 10.49
Return on Investment (TTM) -127.95 7.96 11.78
Return on Investment - 5 Yr. Avg. -- 8.16 13.39
Return on Equity (TTM) -1,220.30 8.11 12.61
Return on Equity - 5 Yr. Avg. -- 9.28 14.86
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ContraVir Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.11 -12.65 54 90
13 Week -28.75 -35.35 25 74
26 Week -58.54 -60.48 20 4
52 Week -89.30 -90.03 8 26
YTD -19.15 -30.23 33 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.51%
# of Holders: 25
Total Shares Held: 727,251
3 Mo. Net Change: -42,811
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.